| |
Beyond the bladder: case series of Mycobacterium bovis bacillus Calmette-Guerin infections following intravesical instillation.
Workman AA, Parra O, Loeven NA, Kaur P, Schroeck FR, Seigne JD, Wang R, Martin IW
ASM Case Rep. 2026 Jul;2(4) doi: 10.1128/asmcr.00207-25. Epub 2026 May 21.
PMID: 42416839 Patterns and Trajectories of Behavioral and Neuropsychiatric Symptoms in Frontotemporal Dementia and Primary Progressive Aphasia.
Marth L, Martinez-Murcia FJ, Gorriz-Saez JM, Denecke J, Ewers M, Prix C, Stockbauer AC, Bernhardt AM, Wagemann O, Wlasich E, Kustermann J, Peters O, Hellmann-Regen J, Droste Zu Senden L, Priller J, Spruth EJ, Spottke A, Asperger H, Schroeck F, Gamez A, Schneider A, Fliessbach K, Dinter E, Linn J, Gunther R, Wiltfang J, Schott BH, Bahr M, Zerr I, Floel A, Malinowski R, Buerger K, Janowitz D, Duzel E, Glanz W, Lusebrink F, Teipel SJ, Kilimann I, Prudlo J, Hermann A, Synofzik M, Mengel D, Beichert L, Muller D, Petzold GC, Yakupov R, Hetzer S, Dechent P, Scheffler K, Schonecker S, Levin J
Neurology. 2026 Feb 24;106(4):e214510. doi: 10.1212/WNL.0000000000214510. Epub 2026 Jan 27.
PMID: 41592266 Diagnostic performance of Cxbladder Triage Plus for the identification and stratification of patients at risk for urothelial carcinoma: The multicenter, prospective, observational DRIVE study.
Savage SJ, Ercole CE, Hemstreet G, Leone A, Masterson T, McWilliams G, Risk M, Schroeck FR, Stratton K, Lough T, de Lange M, Sakamoto K
Urol Oncol. 2026 Jan;44(1):65.e13-65.e20. doi: 10.1016/j.urolonc.2025.10.008. Epub 2025 Nov 1.
PMID: 41176469 Feasibility and outcomes of interventions to reduce cystoscopy discomfort: a multi-site pilot study.
Desai AP, Basak RS, Lotan Y, Sperger J, Schroeck FR, Lipman R, Chaplin I, Roberson H, Lopez P, Jenkins W, Gore JL, Kosorok MR, Smith AB
BJU Int. 2025 Sep;136(3):507-514. doi: 10.1111/bju.16794. Epub 2025 May 24.
PMID: 40411348 Integration and evaluation of implementation strategies to improve guideline-concordant bladder cancer surveillance: a prospective observational study.
Zubkoff L, Ould Ismail AA, Jensen L, Haggstrom DA, Kale S, Issa MM, Tosoian JJ, Siddiqui MM, Bloomquist K, Kimball ER, Zickmund S, Schroeck FR
Implement Sci Commun. 2025 Apr 7;6(1):37. doi: 10.1186/s43058-025-00721-0. Epub 2025 Apr 7.
PMID: 40197353 The Management of Non-Muscle-Invasive Bladder Cancer in a Veteran Patient Population: Issues and Recommendations.
Taylor J, Patel S, Gaitonde K, Greene K, Liao JC, McWilliams G, Sawyer M, Schroeck F, Alrabaa A, Saffati G, Kronstedt S, Jones J
Curr Oncol. 2024 Oct 28;31(11):6686-6698. doi: 10.3390/curroncol31110493. Epub 2024 Oct 28.
PMID: 39590124 Adherence to Synoptic Cancer Pathology Reporting Among Pathologists in the National Department of Veterans Affairs Health Care System.
Ould Ismail AA, Kale S, McGonagle K, Hill B, Pettus JR, DuVall SL, Ferraro JP, Schroeck FR
Arch Pathol Lab Med. 2025 Aug 1;149(8):727-733. doi: 10.5858/arpa.2024-0229-OA.
PMID: 39514644 Non-Muscle Invasive Bladder Cancer: Many More Patients Die With It Than Of It.
McGonagle K, Dematt EJ, Mi Z, Biswas K, Schroeck FR
Bladder Cancer. 2024;10(2):113-117. doi: 10.3233/BLC-230099. Epub 2024 Jun 18.
PMID: 39131873 Editorial Comment on "Teaching Hospitals and Textbook Outcomes After Major Urologic Cancer Surgery".
Schroeck FR
Urology. 2024 Sep;191:71. doi: 10.1016/j.urology.2024.06.066. Epub 2024 Jul 4.
PMID: 38971233 Clinical Trial Protocol for "Replace Cysto": Replacing Invasive Cystoscopy with Urine Testing for Non-muscle-invasive Bladder Cancer Surveillance-A Multicenter, Randomized, Phase 2 Healthcare Delivery Trial Comparing Quality of Life During Cancer Surveillance with Xpert Bladder Cancer Monitor or Bladder EpiCheck Urine Testing Versus Frequent Cystoscopy.
Schroeck FR, Grubb R, MacKenzie TA, Ould Ismail AA, Jensen L, Tsongalis GJ, Lotan Y
Eur Urol Open Sci. 2024 May;63:19-30. doi: 10.1016/j.euros.2024.02.018. Epub 2024 Mar 21.
PMID: 38558761 View more publications on PubMed |